Wednesday, 28 March 2012

Dermatologic Society-Licensing Agreement-Biologic Therapies-Clinical Trial-Prnewswire

Women's Dermatologic Society (WDS) Announces 2012-2013 Leadership and Honorees

ALEXANDRIA, Va., March 28, 2012 /PRNewswire/ -- The Women's Dermatologic Society (WDS), the nation's third largest dermatologic organization, announces its 2012-2013 Officers, Board of Directors and annual honorees, as presented at the 37th Annual Meeting Luncheon held recently in... read more..


First Patient Treated in Trillium's Interstitial Cystitis/Bladder Pain Syndrome Clinical Trial

TORONTO, March 28, 2012 /PRNewswire/ - Trillium Therapeutics Inc., a
privately-held biopharmaceutical company developing proprietary and
innovative biologic therapies, today announced that it has dosed the
first patient in a phase I clinical trial evaluating TTI-1612, an... read more..


Sequent Medical and Inceptus Medical Announce a Licensing Agreement on MicroBraid Technology

ALISO VIEJO, Calif., March 28, 2012 /PRNewswire/ -- Sequent Medical, Inc. and Inceptus Medical, LLC announced today an agreement that provides Inceptus Medical with a license to Sequent Medical's MicroBraid™ technology for use in select medical device applications. Sequent... read more..

No comments:

Post a comment